64 patents
Page 2 of 4
Utility
Steroidal compositions
6 Jul 21
Provided herein are steroid containing compositions suitable for providing therapeutically effective amounts of at least one steroid to individuals.
Chandrashekar Giliyar, Nachiappan Chidambaram, Mahesh V. Patel, Srinivasan Venkateshwaran
Filed: 16 Oct 20
Utility
Steroidal Compositions
17 Jun 21
Provided herein are steroid containing compositions suitable for providing therapeutically effective amounts of at least one steroid to individuals.
Chandrashekar Giliyar, Nachiappan Chidambaram, Mahesh V. Patel, Srinivasan Venkateshwaran
Filed: 24 Feb 21
Utility
Compositions and Their Use In Oral Dosing Regimens
10 Jun 21
Described herein are oral pharmaceutical compositions and their use in testosterone replacement therapy applications.
Mahesh V. Patel, Nachiappan Chidambaram, Satish Nachaegari, Srinivasan Venkateshwaran
Filed: 19 Feb 21
Utility
17-HYDROXYPROGESTERONE Ester-containing Oral Compositions and Related Methods
10 Jun 21
The present invention provides for bioavailable oral dosage forms containing esters of 17-hydroxyprogesterone as well as related methods.
Chandrashekar Giliyar, Srinivasan Venkateshwaran, Basawaraj Chickmath, Satish Nachaegari, Nachiappan Chidambaram, Mahesh V. Patel
Filed: 13 Jul 20
Utility
High-strength testosterone undecanoate compositions
13 Apr 21
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods.
Chandrashekar Giliyar, Basawaraj Chickmath, Nachiappan Chidambaram, Mahesh V. Patel, Srinivansan Venkateshwaran
Filed: 7 Jan 19
Utility
Steroidal Compositions
8 Apr 21
Provided herein are steroid containing compositions suitable for providing therapeutically effective amounts of at least one steroid to individuals.
Chandrashekar Giliyar, Nachiappan Chidambaram, Mahesh V. Patel, Srinivasan Venkateshwaran
Filed: 8 Dec 20
Utility
Bioavailable Solid State (17- β)-HYDROXY-4-ANDROSTEN-3-ONE Esters
11 Mar 21
Disclosed are bioavailable solid state (17-β)-Hydroxy-4-Androsten-3-one esters suitable for pharmaceutical uses and administration to mammals in need of (17-β)-Hydroxy-4-Androsten-3-one.
Mahesh V. Patel, Nachiappan Chidambaram, Satish Kumar Nachaegari, Srinivasan Venkateshwaran, Joel Frank
Filed: 15 Apr 20
Utility
High-strength Testosterone Undecanoate Compositions
25 Feb 21
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods.
Chandrashekar Giliyar, Basawaraj Chickmath, Nachiappan Chidambaram, Mahesh V. Patel, Srinivansan Venkateshwaran
Filed: 8 Apr 20
Utility
Steroidal Compositions
11 Feb 21
Provided herein are steroid containing compositions suitable for providing therapeutically effective amounts of at least one steroid to individuals.
Chandrashekar Giliyar, Nachiappan Chidambaram, Mahesh V. Patel, Srinivasan Venkateshwaran
Filed: 16 Oct 20
Utility
Fixed Dose Oral Testosterone Undecanoate Compositions and Use Thereof
14 Jan 21
Disclosed are effective fixed dose oral testosterone undecanoate compositions for use in regimens without dose titration and methods for treatment of patients in need of testosterone replacement therapy.
Mahesh V. Patel, Nachiappan Chidambaram, Kilyoung Kim
Filed: 25 Sep 20
Utility
Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions
14 Jan 21
The present invention provides solid pharmaceutical compositions for improved delivery of a wide variety of pharmaceutical active ingredients contained therein or separately administered.
Mahesh V. Patel
Filed: 30 Jun 20
Utility
Oral testosterone tridecanoate therapy
4 Jan 21
The present disclosure provides methods and compositions for testosterone replacement therapy.
Nachiappan Chidambaram, Satish Kumar Nachaegari, Mahesh V. Patel, Kilyoung Kim
Filed: 25 Dec 19
Utility
High-strength testosterone undecanoate compositions
4 Jan 21
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods.
Chandrashekar Giliyar, Basawaraj Chickmath, Nachiappan Chidambaram, Mahesh V. Patel, Srinivansan Venkateshwaran
Filed: 7 Apr 20
Utility
Liver Disease
16 Dec 20
Methods of treating a liver disease or condition, or a symptom thereof, in a subject in need of treatment, are disclosed and described.
Mahesh V. Patel, Nachiappan Chidambaram, Satish K. Nachaegari, Burke Byrne, Kilyoung Kim, Jonathan A. Baker
Filed: 24 Aug 20
Utility
High-strength Testosterone Undecanoate Compositions
9 Dec 20
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods.
Chandrashekar Giliyar, Basawaraj Chickmath, Nachiappan Chidambaram, Mahesh V. Patel, Srinivansan Venkateshwaran
Filed: 7 Apr 20
Utility
Liver Disease
9 Dec 20
Methods of treating a liver disease or condition, or a symptom thereof, in a subject in need of treatment, are disclosed and described.
Mahesh V. Patel, Nachiappan Chidambaram, Satish K. Nachaegari, Burke Byrne, Kilyoung Kim, Jonathan A. Baker
Filed: 24 Aug 20
Utility
Steroidal Compositions
9 Dec 20
Provided herein are steroid containing compositions suitable for providing therapeutically effective amounts of at least one steroid to individuals.
Chandrashekar Giliyar, Nachiappan Chidambaram, Mahesh V. Patel, Srinivasan Venkateshwaran
Filed: 12 Mar 20
Utility
High-strength Testosterone Undecanoate Compositions
18 Nov 20
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods.
Chandrashekar Giliyar, Basawaraj Chickmath, Nachiappan Chidambaram, Mahesh V. Patel, Srinivansan Venkateshwaran
Filed: 29 Jul 20
Utility
High-strength testosterone undecanoate compositions
12 Oct 20
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods.
Chandrashekar Giliyar, Basawaraj Chickmath, Nachiappan Chidambaram, Mahesh V. Patel, Srinivansan Venkateshwaran
Filed: 16 Apr 18
Utility
Pharmaceutical Compositions and Dosage Forms for Administration of Hydrophobic Drugs
9 Sep 20
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs, particularly steroids, are provided.
Feng-Jing Chen, Mahesh V. Patel, David T. Fikstad, Huiping Zhang, Chandrashekar Gilyar
Filed: 12 Mar 20